AUM and trading activity drives Oppenheimer's wealth management business. Read why we remain bullish on OPY stock.

YAVNE, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics ...

Alphabet (GOOGL) will be stepping up to the earnings plate tomorrow (February 4), when it will deliver its fourth quarter ...

If you have been looking for Small Cap Growth funds, a place to start could be Oppenheimer Discovery Y (ODIYX). ODIYX possesses a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various ...

Over the years, we’ve heard hundreds of time about how we have enough nuclear weapons to destroy the world. But is that ...

Oppenheimer held steady on its outlook for Take-Two Interactive (NASDAQ:TTWO), maintaining an Outperform rating and a price target of $215.00. With a current market capitalization of $32.2 billion, ...

After the music industry gave out its prestigious Grammys Sunday, the film community is gearing up for its ceremony to take ...

Benny Safdie is the latest actor to join the cast of The Odyssey, the next movie from Christopher Nolan, according to The ...

This year’s Doomsday Clock Statement landed like a damp squib in a Trump-swamped corporate news cycle on January 28th. The ...

In a report released today, Matthew Biegler from Oppenheimer reiterated a Buy rating on Regeneron (REGN – Research Report), with a price target ...

Patient Capital Management stated the following regarding Coinbase Global, Inc. (NASDAQ:COIN) in its Q4 2024 investor letter: ...

Oppenheimer downgraded Apple from "outperform" to "perform" because it is struggling to adapt to a competitive AI landscape.